CTLA4 and autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency: Both CHAI and LATAIE diseases can benefit from targeted treatment with abatacept, a recombinant fusion protein of CTLA4- and Ig Fc, which is a soluble molecule that can replace the function of membrane bound CTLA4 [110, 148].